Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1986-04-03
1989-02-14
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514180, 26039745, A61K 3156, C07J 100
Patent
active
048046566
ABSTRACT:
The invention refers to compounds having anti-inflammatory activity characterized by the formula ##STR1## or a stereoisomeric component thereof, in which formula X.sub.1 represents a hydrogen, chlorine, bromine or fluorine atom;
REFERENCES:
patent: 3828080 (1974-08-01), Phillipps et al.
patent: 3981894 (1976-09-01), Phillipps et al.
patent: 4710495 (1987-12-01), Bodor
Chemical Abstracts; vol. 96 (1982), #163044p; Glaxo Group Ltd.
Chemical Abstracts; vol. 80 (1974), #121208j; Phillips et al.
Chemical Abstracts; vol. 101 (1984), #1027e, Manz et al.
Chemical Abstracts; vol. 97 (1982), #6651n, Bodor.
Andersson Paul H.
Andersson Per T.
Axelsson Bengt I.
Thalen Bror A.
Trofast Jan W.
Aktiebolaget Draco
Lipoysky Joseph A.
Schenkman Leonard
LandOfFree
Novel androstane-17.beta.-carboxylic acid esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel androstane-17.beta.-carboxylic acid esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel androstane-17.beta.-carboxylic acid esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1365666